Table 1

Tumor characteristics

Characteristics *Total (N = 81)NIBC (n = 44)IBC (n = 37)P value
Age, median (range), years58 (24–86)62 (39–86)55 (24–81)0.12
Pev status (81)<0.01
 Pev 0–153 (65%)44 (100%)9 (24%)
 Pev 214 (17.5%)0 (0%)14 (38%)
 Pev 314 (17.5%)0 (0%)14 (38%)
Clinical axillary node status (78)0.07
 N031 (40%)21 (48%)10 (29%)
 N1, N2, N347 (60%)23 (52%)24 (71%)
Histological type (81)0.19
 ductal67 (83%)34 (77%)33 (89%)
 lobular11 (14%)7 (16%)4 (11%)
 other3 (3%)3 (7%)0 (0%)
SBR grade (81)0.07
 1–238 (47%)25 (57%)13 (35%)
 343 (53%)19 (43%)24 (65%)
Dermal lymphatic emboli (81)<0.01
 Present26 (32%)0 (0%)26 (70%)
 Absent55 (68%)44 (100%)11 (30%)
Angioinvasion (79)<0.01
 Present42 (53%)16 (36%)26 (74%)
 Absent37 (47%)28 (64%)9 (26%)
ER status (81)0.36
 Negative32 (39%)15 (34%)17 (46%)
 Positive49 (61%)29 (66%)20 (54%)
PR status (81)0.06
 Negative30 (37%)12 (27%)18 (49%)
 Positive51 (63%)32 (73%)19 (51%)
ERBB2 status (81)0.79
 Negative 0–1+61 (75%)34 (77%)27 (73%)
 Positive 2–3+20 (25%)10 (23%)10 (27%)
P53 status (81)0.35
 Negative51 (63%)29 (66%)22 (59%)
 Positive30 (37%)15 (34%)15 (41%)
  • Note. For all characteristics except age, the values are number of patients with percentage of evaluated cases in parentheses.

  • Abbreviations: Pev 0–1, no inflammatory sign; Pev 2 and Pev 3, localized and extensive inflammatory signs, respectively; SBR, Scarff-Bloom-Richardson.

  • * In this column in parentheses, the number of evaluated cases among 81 patients.

  • Not significant when P > 0.05.